The major histocompatibility complex (MHC) region on chromosome 6p21.32 is the first identified MS risk locus from the candidate-gene era [originally detected over 40 years ago (4, 5)] that is still valid today. This evidence concerns the gene HLA-C and myeloid sarcoma.